April 13, 2005 (Press Release) --
Aethlon Medical Presents at National AIDS Conference
Aethlon Medical, Inc. (OTCBB: AEMD) www.aethlonmedical.com announced that the Company presented yesterday evening at the American Foundation for AIDS Research (amfAR) National HIV/AIDS Update Conference in Oakland, California. The presentation, which highlighted the clinical development of the Aethlon Hemopurifier(TM) to control HIV drug resistance, was given by Aethlon Medical Chief Scientific Officer, Dr. Richard Tullis.
Disclaimer: www.investorideas.com/about/disclaimer
Full News: www.investorideas.com/Companies/ViewDocument.asp?ID=2889
Aethlon Medical, Inc. (OTCBB: AEMD) www.aethlonmedical.com announced that the Company presented yesterday evening at the American Foundation for AIDS Research (amfAR) National HIV/AIDS Update Conference in Oakland, California. The presentation, which highlighted the clinical development of the Aethlon Hemopurifier(TM) to control HIV drug resistance, was given by Aethlon Medical Chief Scientific Officer, Dr. Richard Tullis.
Disclaimer: www.investorideas.com/about/disclaimer
Full News: www.investorideas.com/Companies/ViewDocument.asp?ID=2889

Aethlon Medical, Inc. announced that the Company presented yesterday at the American Foundation for AIDS Research (amfAR) National HIV/AIDS Update Conference in Oakland, California.
Email
Print
SPAM
LEAVE A COMMENT





